Please assess the completion status of the following clinical trial:

Trial Title: PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Social phobic ambulatory subjects, defined according to DSM-IV criteria.~* Must be capable of giving informed consent and can comply with the study requirements.~* Women of childbearing potential must agree to acceptable method of birth control.~Exclusion criteria:~* Primary diagnosis within the past 6 months of other psychiatric conditions such as major depression or another anxiety disorder.~* Use of medications for a psychiatric condition including herbals in the past 2-12 weeks according to medication type.~* Subjects who, in the investigator's judgement pose a current, serious suicidal or homicidal risk or have made a suicide attempt within the past 6 months.~* Subjects who currently meet or who met within 6 months prior to screening DSM-IV criteria for substance abuse or subjects who currently meet or who met within 6 months prior to screening DSM-IV criteria for substance dependence (other than nicotine).~* Significantly abnormal blood or urine laboratory tests or electrocardiogram (ECG) findings.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).